Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,998 DKK | -0.42% | -3.08% | -7.22% |
Apr. 16 | Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug | MT |
Apr. 16 | Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.22% | 18.6B | |
-3.39% | 102B | |
+2.61% | 96.84B | |
-0.64% | 21.48B | |
-18.14% | 20.82B | |
-40.70% | 16.81B | |
-26.89% | 13.78B | |
+1.12% | 13.4B | |
+22.25% | 11.06B | |
-18.85% | 8.88B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Transcript : Genmab A/S - Shareholder/Analyst Call